HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.

Abstract
Placentation is associated with several steps of vascular adaptations throughout pregnancy. These vascular changes occur both on the maternal and fetal sides, consisting of maternal uterine spiral arteries remodeling and placental vasculogenesis and angiogenesis, respectively. Placental angiogenesis is a pivotal process for efficient fetomaternal exchanges and placental development. This process is finely controlled throughout pregnancy, and it involves ubiquitous and pregnancy-specific angiogenic factors. In the last decade, endocrine gland derived vascular endothelial growth factor (EG-VEGF), also called prokineticin 1 (PROK1), has emerged as specific placental angiogenic factor that controls many aspects of normal and pathological placental angiogenesis such as recurrent pregnancy loss (RPL), gestational trophoblastic diseases (GTD), fetal growth restriction (FGR), and preeclampsia (PE). This review recapitulates EG-VEGF mediated-angiogenesis within the placenta and at the fetomaternal interface and proposes that its deregulation might contribute to the pathogenesis of several placental diseases including FGR and PE. More importantly this paper argues for EG-VEGF clinical relevance as a potential biomarker of the onset of pregnancy pathologies and discusses its potential usefulness for future therapeutic directions.
AuthorsNadia Alfaidy, Pascale Hoffmann, Houssine Boufettal, Naima Samouh, Touria Aboussaouira, Mohamed Benharouga, Jean-Jacques Feige, Sophie Brouillet
JournalBioMed research international (Biomed Res Int) Vol. 2014 Pg. 451906 ( 2014) ISSN: 2314-6141 [Electronic] United States
PMID24955357 (Publication Type: Journal Article, Review)
Chemical References
  • Gastrointestinal Hormones
  • PROK1 protein, human
  • Vascular Endothelial Growth Factor, Endocrine-Gland-Derived
Topics
  • Female
  • Gastrointestinal Hormones (genetics, metabolism)
  • Humans
  • Neovascularization, Pathologic (genetics)
  • Neovascularization, Physiologic (genetics)
  • Placenta (metabolism, pathology)
  • Pregnancy
  • Vascular Endothelial Growth Factor, Endocrine-Gland-Derived (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: